Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuroprotective and anti-inflammatory effects of isoliquiritigenin in kainic acid-induced epileptic rats via the TLR4/MYD88 signaling pathway
Xiaobo Zhu, Jiankun Liu, Ou Chen, et al.
Inflammopharmacology (2019) Vol. 27, Iss. 6, pp. 1143-1153
Closed Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Neurochemical regulation of the expression and function of glial fibrillary acidic protein in astrocytes
Dongyang Li, Xiaoyu Liu, Tianming Liu, et al.
Glia (2019) Vol. 68, Iss. 5, pp. 878-897
Closed Access | Times Cited: 123
Modulation of the Innate Immune Response by Targeting Toll-like Receptors: A Perspective on Their Agonists and Antagonists
Stefano Federico, Luca Pozzetti, Alessandro Papa, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 22, pp. 13466-13513
Closed Access | Times Cited: 93
Neuroinflammation in neurological disorders: pharmacotherapeutic targets from bench to bedside
Awanish Mishra, Ritam Bandopadhyay, Prabhakar Singh, et al.
Metabolic Brain Disease (2021) Vol. 36, Iss. 7, pp. 1591-1626
Closed Access | Times Cited: 92
Therapeutic benefits of flavonoids against neuroinflammation: a systematic review
Hamsalakshmi, Ann Maria Alex, Mahalakshmi Arehally Marappa, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 1, pp. 111-136
Closed Access | Times Cited: 47
Isoliquiritigenin, a potential therapeutic agent for treatment of inflammation-associated diseases
Ziyi Chen, Wenwen Ding, Xiaoxue Yang, et al.
Journal of Ethnopharmacology (2023) Vol. 318, pp. 117059-117059
Closed Access | Times Cited: 26
CC Chemokine Family Members’ Modulation as a Novel Approach for Treating Central Nervous System and Peripheral Nervous System Injury—A Review of Clinical and Experimental Findings
A Ciechanowska, Joanna Mika
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3788-3788
Open Access | Times Cited: 9
Natural Chalcones in Chinese Materia Medica: Licorice
Danni Wang, Jing Liang, Jing Zhang, et al.
Evidence-based Complementary and Alternative Medicine (2020) Vol. 2020, Iss. 1
Open Access | Times Cited: 51
Gut Microbiota Disorders Promote Inflammation and Aggravate Spinal Cord Injury Through the TLR4/MyD88 Signaling Pathway
Zijie Rong, Yuliang Huang, Honghua Cai, et al.
Frontiers in Nutrition (2021) Vol. 8
Open Access | Times Cited: 41
The Role of Microglia in the Development of Neurodegenerative Diseases
Jae‐Won Lee, Wanjoo Chun, Hee Jae Lee, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1449-1449
Open Access | Times Cited: 41
The role of prolactin in central nervous system inflammation
Edgar Ramos-Martínez, Iván Ramos-Martínez, Gladys Molina-Salinas, et al.
Reviews in the Neurosciences (2021) Vol. 32, Iss. 3, pp. 323-340
Open Access | Times Cited: 40
Pharmacological Effects and Underlying Mechanisms of Licorice-Derived Flavonoids
Yufan Wu, Zhuxian Wang, Qunqun Du, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-25
Open Access | Times Cited: 30
Role of Innate Immune Receptor TLR4 and its endogenous ligands in epileptogenesis
Yam Nath Paudel, Efthalia Angelopoulou, Enes Akyüz, et al.
Pharmacological Research (2020) Vol. 160, pp. 105172-105172
Closed Access | Times Cited: 39
Mechanistic insight into immunomodulatory effects of food-functioned plant secondary metabolites
A.S.M. Ali Reza, Shamima Nasrin, Md. Amjad Hossen, et al.
Critical Reviews in Food Science and Nutrition (2021) Vol. 63, Iss. 22, pp. 5546-5576
Closed Access | Times Cited: 39
Chalcones reverse the anxiety and convulsive behavior of adult zebrafish
Maria Kueirislene Amâncio Ferreira, Antônio Wlisses da Silva, Atilano Lucas dos Santos Moura, et al.
Epilepsy & Behavior (2021) Vol. 117, pp. 107881-107881
Closed Access | Times Cited: 36
Ferroptosis and Pyroptosis in Epilepsy
Fan Feng, Rong Luo, Dezhi Mu, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 10, pp. 7354-7368
Closed Access | Times Cited: 4
Changes in macrophage inflammatory protein-1 (MIP-1) family members expression induced by traumatic brain injury in mice
A Ciechanowska, Katarzyna Popiołek-Barczyk, Katarzyna Pawlik, et al.
Immunobiology (2020) Vol. 225, Iss. 3, pp. 151911-151911
Closed Access | Times Cited: 32
Isoliquiritigenin, a potent human monoamine oxidase inhibitor, modulates dopamine D1, D3, and vasopressin V1A receptors
Ritu Prajapati, Su Hui Seong, Se Eun Park, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 24
Pathological Targets for Treating Temporal Lobe Epilepsy: Discoveries From Microscale to Macroscale
Jing You, Haiyan Huang, Clement T. Y. Chan, et al.
Frontiers in Neurology (2022) Vol. 12
Open Access | Times Cited: 16
Neurotrophic, anti-neuroinflammatory, and redox balance mechanisms of chalcones
Temitope Isaac Adelusi, Gbemisola Rebecca Akinbolaji, Xiaoxing Yin, et al.
European Journal of Pharmacology (2020) Vol. 891, pp. 173695-173695
Closed Access | Times Cited: 24
Baicalin Rescues Cognitive Dysfunction, Mitigates Neurodegeneration, and Exerts Anti-Epileptic Effects Through Activating TLR4/MYD88/Caspase-3 Pathway in Rats
Jiali Yang, Zhixia Jia, Zhigang Xiao, et al.
Drug Design Development and Therapy (2021) Vol. Volume 15, pp. 3163-3180
Open Access | Times Cited: 21
Exploring the Neuroinflammatory Pathway in Epilepsy and Cognitive Impairment: Role of HMGB1 and Translational Challenges
Irma Wati Ngadimon, Eryse Amira Seth, Mohd. Farooq Shaikh
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 6, pp. 229-229
Open Access | Times Cited: 2
Isoliquiritigenin alleviates neuropathic pain by reducing microglia inflammation through inhibition of the ERK signaling pathway and decreasing CEBPB transcription expression
Zikun Wang, Shu Jia, Xiaozheng Kang, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113536-113536
Open Access | Times Cited: 2
Metformin ameliorates the status epilepticus- induced hippocampal pathology through possible mTOR modulation
Sree Lalitha Bojja, Bikash Medhi, Shashi Anand, et al.
Inflammopharmacology (2021) Vol. 29, Iss. 1, pp. 137-151
Closed Access | Times Cited: 18
Anti-inflammation of isoliquiritigenin via the inhibition of NF-κB and MAPK in LPS-stimulated MAC-T cells
Manman Li, Guicong Lu, Xiao Ma, et al.
BMC Veterinary Research (2022) Vol. 18, Iss. 1
Open Access | Times Cited: 13
Isoliquiritigenin induces neurodevelopmental-toxicity and anxiety-like behavior in zebrafish larvae
Lizhen Wang, Lei Mou, Shibing Guan, et al.
Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology (2023) Vol. 266, pp. 109555-109555
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top